Friday, 7 Aug 2020

CARLYLE

Carlyle buys 20% stake in Piramal Pharma businesses

(Reuters) – U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490 million, the companies said in a statement on Saturday. Piramal Pharma will use the capital injection to accelerate its organic and inorganic growth plans, the statement said. The investment […]

Carlyle buys 20% stake in Piramal Pharma businesses

(Reuters) – U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in India’s Piramal Enterprises Ltd’s pharmaceutical businesses for about $490 million, the companies said in a statement on Saturday. The capital increase aims to accelerate Piramal Pharma’s organic and inorganic growth plans, according to the statement. Source: Read Full Article